- Home
- COEP vs RADX Comparison
COEP vs RADX Comparison
Compare COEP & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- RADX
- Stock Information
- Founded
- COEP 2017
- RADX 2021
- Country
- COEP United States
- RADX Australia
- Employees
- COEP N/A
- RADX N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- RADX
- Sector
- COEP Health Care
- RADX
- Exchange
- COEP Nasdaq
- RADX NYSE
- Market Cap
- COEP 27.4M
- RADX 32.5M
- IPO Year
- COEP N/A
- RADX N/A
- Fundamental
- Price
- COEP $9.75
- RADX $4.42
- Analyst Decision
- COEP
- RADX Strong Buy
- Analyst Count
- COEP 0
- RADX 2
- Target Price
- COEP N/A
- RADX $13.50
- AVG Volume (30 Days)
- COEP 37.4K
- RADX 18.6K
- Earning Date
- COEP 08-15-2025
- RADX 02-26-2025
- Dividend Yield
- COEP N/A
- RADX N/A
- EPS Growth
- COEP N/A
- RADX N/A
- EPS
- COEP N/A
- RADX N/A
- Revenue
- COEP $62,874.00
- RADX $204,609.00
- Revenue This Year
- COEP N/A
- RADX N/A
- Revenue Next Year
- COEP N/A
- RADX N/A
- P/E Ratio
- COEP N/A
- RADX N/A
- Revenue Growth
- COEP N/A
- RADX N/A
- 52 Week Low
- COEP $2.31
- RADX $3.50
- 52 Week High
- COEP $13.70
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- COEP 65.80
- RADX N/A
- Support Level
- COEP $7.25
- RADX N/A
- Resistance Level
- COEP $9.90
- RADX N/A
- Average True Range (ATR)
- COEP 0.57
- RADX 0.00
- MACD
- COEP 0.30
- RADX 0.00
- Stochastic Oscillator
- COEP 100.00
- RADX 0.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.